植物治疗,顺势疗法干预和蜂产品治疗儿科感染:一个范围审查
Camilla Bertoni1, Ilaria Alberti2, Niccolò Parri3
1Department of Veterinary Sciences for Health, Animal Production and Food Safety, University of Milan, 20122 Milan, Italy.
Nutrients
|October 16, 2025
概括
植物治疗剂和蜜蜂产品对急性儿科呼吸道感染有希望,但对顺势疗法和其他感染的证据有限. 对于儿童的这些替代治疗方法,需要更多的研究.
科学领域:
- 儿童传染病 儿童传染病
- 补充和替代医学 补充和替代医学
- 基于证据的实践.
背景情况:
- 急性儿科感染导致过度使用抗生素.
- 植物疗法,顺势疗法和蜜蜂产品被探索为替代品.
- 对于儿童感染的非抗生素治疗的证据有限.
研究的目的:
- 绘制关于植物治疗,顺势疗法和蜂产品在急性儿科感染中的疗效和安全性的证据.
- 确定儿童感染非抗生素干预的研究缺口.
- 为临床实践和未来研究方向提供信息.
主要方法:
- 对多个数据库进行范围审查.
- 包括关于植物疗法,顺势疗法和儿童蜂产品的研究.
- 由于现有的益生菌研究,排除了胃肠道感染.
主要成果:
- 植物疗法和蜜蜂产品显示出呼吸道感染的潜力 (症状严重程度和持续时间).
- 顺势疗法证据有限且不一致;安全性一般适用于所有干预措施.
- 尿道,皮肤,骨关节和神经系统感染的数据稀缺.
结论:
- 植物疗法和蜜蜂产品在儿童急性上呼吸道感染和支气管炎方面提供了令人鼓舞的疗效和安全信号.
- 对于其他儿科感染,如中耳炎和胃肠道感染,存在显著的证据差距.
- 进一步的高质量的临床试验对于确定植物疗法和顺势疗法在儿科传染病中的作用至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
191
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
191
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
241
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241


